Rising Pharma Holding, Inc.: Drug Recall

Recall #D-0029-2026 · 10/07/2025

Class II: Risk

Recall Details

Recall Number
D-0029-2026
Classification
Class II
Product Type
Drug
Recalling Firm
Rising Pharma Holding, Inc.
Status
Ongoing
Date Initiated
10/07/2025
Location
East Brunswick, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,064 100-count bottles

Reason for Recall

Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).

Product Description

Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01

Distribution Pattern

Distributed Nationwide in the USA

Other Recalls by Rising Pharma Holding, Inc.

View all recalls by Rising Pharma Holding, Inc. →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.